How much is Rani Therapeutics worth in 2026?

Rani Therapeutics has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has Rani Therapeutics raised?

Rani Therapeutics has raised N/A in total funding across 1 funding rounds.

Rani Therapeutics

Drug Delivery

Rani Therapeutics valuation and funding history | Last updated: October 23, 2025 | 1 funding rounds

Current Valuation

N/A

As of October 23, 2025

Total Funding Raised

N/A

Across 1 round

Last Round

PIPE

$20.5M

Last Funding

Oct 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
October 23, 2025	PIPE	$20.5M	N/A	-

Valuation Analysis

Current Valuation Metrics

Rani Therapeutics is currently valued at N/A as of October 23, 2025.

Track Rani Therapeutics Valuation Updates

Get notified when Rani Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Rani Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Rani Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Rani Therapeutics Worth in 2026?

Rani Therapeutics is a leading private company in the Drug Delivery sector. Track Rani Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Rani Therapeutics Valuation is Determined

Private company valuations like Rani Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.